SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ANG Lifesciences to acquire 51% stake in Baddi Agro

09 Nov 2021 Evaluate

ANG Lifesciences India's board is all set to invest in the Equity Shares and Redeemable Cumulative Preference Shares of Baddi Agro. Consequent to the acquisition of 51% Equity stake by the company, Baddi Agro will become the subsidiary company of ANG Lifesciences India. The object of the said acquisition is to expand its business activities for manufacturing of Menthol API Derivative and other related products. The company's Board of Directors in their meeting held on November 8, 2021 had decided the same.

ANG Lifesciences India, incorporated in the year 2006, started with the business of manufacturing and marketing of finished pharmaceutical formulation in a dosage form of Sterile Dry Powder Injection Vial.

ANG Lifesciences Share Price

27.40 -0.11 (-0.40%)
11-May-2026 13:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.50
Dr. Reddys Lab 1294.15
Cipla 1321.15
Zydus Lifesciences 948.00
Lupin 2275.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×